New search | Conferencedetail
mail
Print view
 
 

3rd Annual Ligase Targeting Drug Development Summit

Evvnt Promotion / evvnt
-
11.04.2023 - 13.04.2023  Hilton Boston Logan Airport, One Hotel Drive, 02128 Boston, Massachusetts, USA
Time: 9:00 am to 5:00 pm
 
Conference themes
From discovery to clinical development, the field of protein degradation is booming with excitement, with a whole host of investments and new companies joining the effort to successfully degrade unwanted or undrugged targets with key roles in a broad range of diseases from oncology to CNS, through to autoimmune.

Despite this, key challenges remain to rapidly and successfully discover novel and underexploited Ubiquitin E3 ligases.
Scientific Society
Hanson Wade
Notes
Speakers: Kirby Swatek, Principal Investigator, University of Dundee, Ian Churcher, Chief Scientific Officer, Amphista Therapeutics, David Duda, Senior Scientist, Johnson and Johnson and more.
 

Enquiries and Registration:

https://go.evvnt.com/1450513-2?pid=4832
Mr. Alex Domingo
 
Categories
Health Services, Public Health
Languages
English
Congress fees
USD 2599.00 - USD 5846.00
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Center of ExcellenceOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Österreichische Akademie der ÄrzteAGEM - Arbeitsgemeinschaft Ethnologie und MedizinHilfswerk AustriaAnästhesie in Entwicklungsländern e. V.Österreichische Gesellschaft für Public HealthEuropean Health Forum Gastein